KVUE's stock performance has suffered from legacy investor selling, management turnover, litigation risks, and a profit ...

Add in the steady cash returns from dividend stocks, and you can further increase your potential total returns. With this in ...

Kenvue has a lower P/E than the aggregate P/E of 55.57 of the Personal Products industry. Ideally, one might believe that the ...

Texas Attorney General Ken Paxton said he scored what he calls a "major win" against pharmaceutical giant Johnson & Johnson ...

Kimberly-Clark stock provides an interesting opportunity amid the $48.7 billion Kenvue acquisition. Learn more about KVUE and ...

The combination would create a giant health and personal care business. Kimberly Clark 's ( KMB 0.69%) offer included mostly stock instead of cash. *Stock prices used were the afternoon prices of Dec.

Kimberly-Clark is acquiring Kenvue, creating a health and wellness giant with $32 billion in revenue and 10 brands generating ...

Attorney General Paxton secured a court order against Johnson & Johnson and Kenvue for operating without proper registration ...

When Kimberly-Clark (KMB) bid for Kenvue (KVUE), sellers sent its shares to a low of $99.22. KMB stock traded between $120 - $150.45 before its proposal to buy the Tylenol pain relief supplier. Kenvue ...

This was the stock's second consecutive day of gains.

Tylenol-maker Kenvue Inc. must comply with a Texas law requiring out-of-state businesses to register with the state or risk being barred from conducting business in Texas, a judge ruled.